Corbus Pharmaceuticals Holdings Book Value Per Share Growth & History (CRBP)
Corbus Pharmaceuticals Holdings's book value per share was $8.38 for fiscal 2025.
View full Corbus Pharmaceuticals Holdings company overviewCorbus Pharmaceuticals Holdings annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $8.38 | -$3.32 | −28.38% |
| 2024 | 2024-12-31 | $11.69 | $13.26 | — |
| 2023 | 2023-12-31 | -$1.56 | -$9.47 | — |
| 2022 | 2022-12-31 | $7.91 | -$8.67 | −52.28% |
| 2021 | 2021-12-31 | $16.57 | $2.83 | +20.63% |
| 2020 | 2020-12-31 | $13.74 | $10.88 | +381.04% |
| 2019 | 2019-12-31 | $2.86 | -$11.57 | −80.20% |
| 2018 | 2018-12-31 | $14.42 | -$16.75 | −53.73% |
| 2017 | 2017-12-31 | $31.18 | $25.19 | +420.60% |
| 2016 | 2016-12-31 | $5.99 | -$1.18 | −16.45% |
| 2015 | 2015-12-31 | $7.17 | $0.39 | +5.71% |
| 2014 | 2014-12-31 | $6.78 | $14.46 | — |
| 2013 | 2013-12-31 | -$7.68 | — | — |
Corbus Pharmaceuticals Holdings quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $5.48 | -$3.58 | −39.54% |
| Q1 2026 | 2026-03-31 | $7.12 | -$3.27 | −31.45% |
| Q4 2025 | 2025-12-31 | $8.38 | -$3.32 | −28.38% |
| Q3 2025 | 2025-09-30 | $7.35 | -$5.01 | −40.51% |
| Q2 2025 | 2025-06-30 | $9.06 | -$1.86 | −17.04% |
| Q1 2025 | 2025-03-31 | $10.39 | $1.16 | +12.59% |
| Q4 2024 | 2024-12-31 | $11.69 | $13.26 | — |
| Q3 2024 | 2024-09-30 | $12.36 | $12.29 | +17419.89% |
| Q2 2024 | 2024-06-30 | $10.92 | $8.77 | +407.16% |
| Q1 2024 | 2024-03-31 | $9.23 | $5.32 | +136.34% |
| Q4 2023 | 2023-12-31 | -$1.56 | -$9.47 | — |
| Q3 2023 | 2023-09-30 | $0.07 | -$9.97 | −99.30% |
| Q2 2023 | 2023-06-30 | $2.15 | -$9.69 | −81.83% |
| Q1 2023 | 2023-03-31 | $3.90 | -$10.74 | −73.34% |
| Q4 2022 | 2022-12-31 | $7.91 | -$8.67 | −52.28% |
| Q3 2022 | 2022-09-30 | $10.04 | -$8.55 | −45.99% |
| Q2 2022 | 2022-06-30 | $11.85 | -$6.61 | −35.81% |
| Q1 2022 | 2022-03-31 | $14.65 | -$7.31 | −33.29% |
| Q4 2021 | 2021-12-31 | $16.57 | $2.83 | +20.63% |
| Q3 2021 | 2021-09-30 | $18.60 | $7.93 | +74.36% |
| Q2 2021 | 2021-06-30 | $18.46 | $0.45 | +2.50% |
| Q1 2021 | 2021-03-31 | $21.96 | $12.57 | +133.83% |
| Q4 2020 | 2020-12-31 | $13.74 | $10.88 | +381.04% |
| Q3 2020 | 2020-09-30 | $10.67 | -$3.08 | −22.43% |
| Q2 2020 | 2020-06-30 | $18.01 | -$3.98 | −18.09% |
| Q1 2020 | 2020-03-31 | $9.39 | -$10.30 | −52.30% |
| Q4 2019 | 2019-12-31 | $2.86 | -$11.57 | −80.20% |
| Q3 2019 | 2019-09-30 | $13.75 | -$8.72 | −38.81% |
| Q2 2019 | 2019-06-30 | $21.99 | -$7.12 | −24.46% |
| Q1 2019 | 2019-03-31 | $19.69 | -$14.72 | −42.78% |
| Q4 2018 | 2018-12-31 | $14.42 | -$16.75 | −53.73% |
| Q3 2018 | 2018-09-30 | $22.47 | $3.37 | +17.62% |
| Q2 2018 | 2018-06-30 | $29.10 | $6.65 | +29.62% |
| Q1 2018 | 2018-03-31 | $34.41 | $8.33 | +31.96% |
| Q4 2017 | 2017-12-31 | $31.18 | $25.19 | +420.60% |
| Q3 2017 | 2017-09-30 | $19.10 | $10.02 | +110.37% |
| Q2 2017 | 2017-06-30 | $22.45 | $10.35 | +85.47% |
| Q1 2017 | 2017-03-31 | $26.08 | $20.97 | +410.43% |
| Q4 2016 | 2016-12-31 | $5.99 | -$1.18 | −16.45% |
| Q3 2016 | 2016-09-30 | $9.08 | $0.17 | +1.87% |
| Q2 2016 | 2016-06-30 | $12.11 | $5.50 | +83.28% |
| Q1 2016 | 2016-03-31 | $5.11 | -$0.30 | −5.61% |
| Q4 2015 | 2015-12-31 | $7.17 | $0.39 | +5.71% |
| Q3 2015 | 2015-09-30 | $8.91 | $0.76 | +9.28% |
| Q2 2015 | 2015-06-30 | $6.60 | — | — |
| Q1 2015 | 2015-03-31 | $5.41 | — | — |
| Q4 2014 | 2014-12-31 | $6.78 | $14.46 | — |
| Q3 2014 | 2014-09-30 | $8.16 | — | — |
| Q4 2013 | 2013-12-31 | -$7.68 | — | — |
Corbus Pharmaceuticals Holdings book value per share trends
Over the last five fiscal years, Corbus Pharmaceuticals Holdings's book value per share decreased from $13.74 to $8.38, a change of -$5.36. The latest reported quarter, Q2 2026, shows $5.48.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Corbus Pharmaceuticals Holdings source filings ↗